Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Mkhize NN, Zhang B, Brackett C, Elyanu PJ, Tapley A, Dadabhai S, Hu J, Do BTN, Schuster DJ, Heptinstall J, Sawant S, Seaton K, Sarzotti-Kelsoe M, Hudson A, Jin Y, Bhebhe S, Kaldine H, Kgagudi P, Modise T, Mgodi NM, Andriesen J, Randhawa AK, Fisher LH, Kee JJ, Magaret CA, Peng J, Kenny A, Carpp LN, Chen Z, Heng S, Villaran M, Takalani A, Le Roux B, Wilkinson E, Odhiambo J, Shah P, Polakowski L, Yacovone M, Samandari T, Chirenje Z, Makhema J, Kamuti E, Njekwa K, Nuwagaba-Biribonwoha H, Baguma A, Badal-Faesen S, Brumskine W, Coetzer S, Dawson R, Delany-Moretlwe S, Diacon AH, Fry S, Gill K, Madikida A, Hoosain ZAE, Hosseinipour MC, Inambao M, Innes C, Innes S, Kalonji D, Mwape H, Kassim P, Kamanga MC, Kilembe W, Laher F, Malahleha M, Maluleke VL, Mboya G, Madiega PA, McHarry K, Mitha E, Duki Y, Mda P, Moerane M, Moloantoa T, Nuwamanya S, Mahomed S, Naicker V, Nana A, Nanvubya A, Kawoozo B, Nchabeleng M, Otieno W, Potgieter EL, Potloane D, Punt Z, Said J, Singh Y, Kassim S, van der Vendt D, Tayob MS, Vahed Y, Wabwire DO, Kublin JG, Bekker LG, Corey L, Gray GE, Huang Y, Kotze P, Garrett N, Hural J, Ferrari G, Andersen-Nissen E, Montefiori D, Moore PL, McElrath MJ, Tomaras GD, Gilbert PB, CoVPN 3008 Study Team

Open source

DOI
10.1038/s41467-025-63948-4
Published
2025 Oct 6
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-63948-4,
  title = {Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.},
  author = {Mkhize NN and Zhang B and Brackett C and Elyanu PJ and Tapley A and Dadabhai S and Hu J and Do BTN and Schuster DJ and Heptinstall J and Sawant S and Seaton K and Sarzotti-Kelsoe M and Hudson A and Jin Y and Bhebhe S and Kaldine H and Kgagudi P and Modise T and Mgodi NM and Andriesen J and Randhawa AK and Fisher LH and Kee JJ and Magaret CA and Peng J and Kenny A and Carpp LN and Chen Z and Heng S and Villaran M and Takalani A and Le Roux B and Wilkinson E and Odhiambo J and Shah P and Polakowski L and Yacovone M and Samandari T and Chirenje Z and Makhema J and Kamuti E and Njekwa K and Nuwagaba-Biribonwoha H and Baguma A and Badal-Faesen S and Brumskine W and Coetzer S and Dawson R and Delany-Moretlwe S and Diacon AH and Fry S and Gill K and Madikida A and Hoosain ZAE and Hosseinipour MC and Inambao M and Innes C and Innes S and Kalonji D and Mwape H and Kassim P and Kamanga MC and Kilembe W and Laher F and Malahleha M and Maluleke VL and Mboya G and Madiega PA and McHarry K and Mitha E and Duki Y and Mda P and Moerane M and Moloantoa T and Nuwamanya S and Mahomed S and Naicker V and Nana A and Nanvubya A and Kawoozo B and Nchabeleng M and Otieno W and Potgieter EL and Potloane D and Punt Z and Said J and Singh Y and Kassim S and van der Vendt D and Tayob MS and Vahed Y and Wabwire DO and Kublin JG and Bekker LG and Corey L and Gray GE and Huang Y and Kotze P and Garrett N and Hural J and Ferrari G and Andersen-Nissen E and Montefiori D and Moore PL and McElrath MJ and Tomaras GD and Gilbert PB and CoVPN 3008 Study Team},
  year = {2025},
  journal = {Nature communications},
  doi = {10.1038/s41467-025-63948-4},
  url = {https://doi.org/10.1038/s41467-025-63948-4}
}

RIS

TY  - JOUR
TI  - Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.
AU  - Mkhize NN
AU  - Zhang B
AU  - Brackett C
AU  - Elyanu PJ
AU  - Tapley A
AU  - Dadabhai S
AU  - Hu J
AU  - Do BTN
AU  - Schuster DJ
AU  - Heptinstall J
AU  - Sawant S
AU  - Seaton K
AU  - Sarzotti-Kelsoe M
AU  - Hudson A
AU  - Jin Y
AU  - Bhebhe S
AU  - Kaldine H
AU  - Kgagudi P
AU  - Modise T
AU  - Mgodi NM
AU  - Andriesen J
AU  - Randhawa AK
AU  - Fisher LH
AU  - Kee JJ
AU  - Magaret CA
AU  - Peng J
AU  - Kenny A
AU  - Carpp LN
AU  - Chen Z
AU  - Heng S
AU  - Villaran M
AU  - Takalani A
AU  - Le Roux B
AU  - Wilkinson E
AU  - Odhiambo J
AU  - Shah P
AU  - Polakowski L
AU  - Yacovone M
AU  - Samandari T
AU  - Chirenje Z
AU  - Makhema J
AU  - Kamuti E
AU  - Njekwa K
AU  - Nuwagaba-Biribonwoha H
AU  - Baguma A
AU  - Badal-Faesen S
AU  - Brumskine W
AU  - Coetzer S
AU  - Dawson R
AU  - Delany-Moretlwe S
AU  - Diacon AH
AU  - Fry S
AU  - Gill K
AU  - Madikida A
AU  - Hoosain ZAE
AU  - Hosseinipour MC
AU  - Inambao M
AU  - Innes C
AU  - Innes S
AU  - Kalonji D
AU  - Mwape H
AU  - Kassim P
AU  - Kamanga MC
AU  - Kilembe W
AU  - Laher F
AU  - Malahleha M
AU  - Maluleke VL
AU  - Mboya G
AU  - Madiega PA
AU  - McHarry K
AU  - Mitha E
AU  - Duki Y
AU  - Mda P
AU  - Moerane M
AU  - Moloantoa T
AU  - Nuwamanya S
AU  - Mahomed S
AU  - Naicker V
AU  - Nana A
AU  - Nanvubya A
AU  - Kawoozo B
AU  - Nchabeleng M
AU  - Otieno W
AU  - Potgieter EL
AU  - Potloane D
AU  - Punt Z
AU  - Said J
AU  - Singh Y
AU  - Kassim S
AU  - van der Vendt D
AU  - Tayob MS
AU  - Vahed Y
AU  - Wabwire DO
AU  - Kublin JG
AU  - Bekker LG
AU  - Corey L
AU  - Gray GE
AU  - Huang Y
AU  - Kotze P
AU  - Garrett N
AU  - Hural J
AU  - Ferrari G
AU  - Andersen-Nissen E
AU  - Montefiori D
AU  - Moore PL
AU  - McElrath MJ
AU  - Tomaras GD
AU  - Gilbert PB
AU  - CoVPN 3008 Study Team
PY  - 2025
JO  - Nature communications
DO  - 10.1038/s41467-025-63948-4
UR  - https://doi.org/10.1038/s41467-025-63948-4
ER  - 

APA

NN, M., B, Z., C, B., PJ, E., A, T., S, D., J, H., BTN, D., DJ, S., J, H., S, S., K, S., M, S., A, H., Y, J., S, B., H, K., P, K., T, M., NM, M., J, A., AK, R., LH, F., JJ, K., CA, M., J, P., A, K., LN, C., Z, C., S, H., M, V., A, T., B, L. R., E, W., J, O., P, S., L, P., M, Y., T, S., Z, C., J, M., E, K., K, N., H, N., A, B., S, B., W, B., S, C., R, D., S, D., AH, D., S, F., K, G., A, M., ZAE, H., MC, H., M, I., C, I., S, I., D, K., H, M., P, K., MC, K., W, K., F, L., M, M., VL, M., G, M., PA, M., K, M., E, M., Y, D., P, M., M, M., T, M., S, N., S, M., V, N., A, N., A, N., B, K., M, N., W, O., EL, P., D, P., Z, P., J, S., Y, S., S, K., D, V. D. V., MS, T., Y, V., DO, W., JG, K., LG, B., L, C., GE, G., Y, H., P, K., N, G., J, H., G, F., E, A., D, M., PL, M., MJ, M., GD, T., PB, G., & Team, C. 3. S. (2025). Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.. Nature communications. https://doi.org/10.1038/s41467-025-63948-4

Source records